LifeMD to Report Second Quarter 2024 Financial Results on August 7
LifeMD (Nasdaq: LFMD), a leading virtual primary care provider, has announced it will release its Q2 2024 financial results on August 7, 2024, after U.S. financial markets close. The company will host a conference call at 4:30 p.m. Eastern time on the same day to discuss the results. Investors can access the call via toll-free (1-800-245-3047) or international (1-203-518-9765) dial-in numbers, using the conference ID: LIFEMD. A live and archived webcast of the call will also be available.
LifeMD (Nasdaq: LFMD), un importante fornitore di assistenza primaria virtuale, ha annunciato che rilascerà i suoi risultati finanziari del Q2 2024 il 7 agosto 2024, dopo la chiusura dei mercati finanziari statunitensi. L'azienda ospiterà una conference call alle 16:30 ora orientale dello stesso giorno per discutere i risultati. Gli investitori possono accedere alla chiamata tramite numeri senza spese (1-800-245-3047) o numeri internazionali (1-203-518-9765), utilizzando l'ID conferenza: LIFEMD. Anche un webcast in diretta e registrato della chiamata sarà disponibile.
LifeMD (Nasdaq: LFMD), un proveedor líder de atención primaria virtual, ha anunciado que publicará sus resultados financieros del Q2 2024 el 7 de agosto de 2024, después de que cierren los mercados financieros de EE.UU. La compañía llevará a cabo una conferencia telefónica a las 4:30 p.m. hora del Este del mismo día para discutir los resultados. Los inversores pueden acceder a la llamada a través de números gratuitos (1-800-245-3047) o internacionales (1-203-518-9765), utilizando el ID de la conferencia: LIFEMD. También estará disponible una transmisión web en vivo y archivada de la llamada.
LifeMD (Nasdaq: LFMD)는 선도적인 가상 1차 진료 제공업체로서, 2024년 2분기 재무 결과를 2024년 8월 7일, 미국 금융 시장이 닫힌 후에 발표하겠다고 발표했습니다. 회사는 같은 날 동부 표준시 오후 4시 30분에 결과를 논의하기 위한 컨퍼런스 콜을 주최할 예정입니다. 투자자들은 무료 전화번호 (1-800-245-3047) 또는 국제 전화번호 (1-203-518-9765)를 통해 호출에 접속할 수 있으며, 컨퍼런스 ID: LIFEMD를 사용해야 합니다. 전화의 생중계 및 아카이브 웹캐스트도 제공될 예정입니다.
LifeMD (Nasdaq: LFMD), un fournisseur de soins de santé primaires virtuels de premier plan, a annoncé qu'il publiera ses résultats financiers du Q2 2024 le 7 août 2024, après la fermeture des marchés financiers américains. La société organisera une conférence téléphonique à 16h30, heure de l'Est le même jour pour discuter des résultats. Les investisseurs peuvent accéder à l'appel via les numéros gratuits (1-800-245-3047) ou internationaux (1-203-518-9765), en utilisant l'ID de conférence : LIFEMD. Un webinaire en direct et archivé de l'appel sera également disponible.
LifeMD (Nasdaq: LFMD), ein führender Anbieter virtueller Primärversorgung, hat angekündigt, seine Finanzergebnisse für Q2 2024 am 7. August 2024 nach Schließung der US-Finanzmärkte zu veröffentlichen. Das Unternehmen wird am selben Tag um 16:30 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. Investoren können sich über die gebührenfreie Nummer (1-800-245-3047) oder die internationale Nummer (1-203-518-9765) einwählen, wobei die Konferenz-ID: LIFEMD verwendet werden muss. Eine Live-Übertragung sowie eine archivierte Webcast der Konferenz werden ebenfalls verfügbar sein.
- None.
- None.
NEW YORK, July 30, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, 2024 after the close of the U.S. financial markets on August 7, 2024 and will host a conference call beginning at 4:30 p.m. Eastern time.
Conference Call & Webcast Details
| Date: | Wednesday, August 7th |
| Time: | 4:30 p.m. Eastern time |
| Toll-Free Dial-In: | 1-800-245-3047 |
| International Dial-In: | 1-203-518-9765 |
| Conference ID: | LIFEMD |
| Live & Archived Webcast: | Link |
About LifeMD, Inc.
LifeMD is a leading provider of virtual primary care. LifeMD offers telemedicine, laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women's health, weight management, and hormone therapy. The Company leverages a vertically-integrated, proprietary digital care platform, a 50-state affiliated medical group, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit LifeMD.com.
Investor Contact
Marc Benathen, Chief Financial Officer
marc@lifemd.com
Media Contact
Jessica Friedeman, Chief Marketing Officer
press@lifemd.com
FAQ
When will LifeMD (LFMD) report its Q2 2024 financial results?
What time is LifeMD's (LFMD) Q2 2024 earnings conference call?
How can investors access LifeMD's (LFMD) Q2 2024 earnings call?
What period will LifeMD's (LFMD) Q2 2024 financial results cover?
